Xia Guo

4PUBLICATIONS
3CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 26, 2025
YTHDF3 suppresses interferon-stimulated gene (ISG)-dependent antitumor immunity and promotes HPV carcinogenesis in cervical cancer.

Li Li, Dongmei Lin, Keyi Ao

|Dec 04, 2025
Targeted NAT10 Degradation by PROTAC NP1192 Suppresses Hypoxia-Adaptive Glycolysis and Reinvigorates CD8<sup>+</sup> Effector T‑Cell Function for Synergistic Cancer Immunotherapy.

Keyi Ao, Zhiqiang Sun, Yi Hao

|Oct 11, 2023
NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer.

Xiaona Chen, Yi Hao, Yong Liu

|Feb 19, 2021
Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer.

Yi Hao, Ming Ye, Xiaona Chen

Pageof 1

Frequent Collaborators

1 joint publications

Jianjun Chen

1 joint publications

Xin Li

1 joint publications

Yi Hao